Sign In
Buy SRDX
$42.98
+0 (+0%)
At Close: Feb 24, 2026
Add These 4 Top-Performing Liquid Stocks for Strong Returns
08:49am, Friday, 18'th Aug 2023
Here are four top-ranked liquid stocks, Dr. Reddy's (RDY), Surmodics (SRDX), Fluor Corporation (FLR) and GigaCloud Technology (GCT), which investors can add to their portfolio for solid gains.
Surmodics to Participate in Upcoming Investor Conferences in August
05:05pm, Wednesday, 09'th Aug 2023
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #Needham--SRDX, a provider of medical device and in vitro diagnostic technologies, announced management will participate in upcoming investor conferences.
Surmodics, Inc. (SRDX) Q3 2023 Earnings Call Transcript
09:00am, Sunday, 06'th Aug 2023
Surmodics, Inc. (NASDAQ:SRDX ) Q3 2023 Earnings Conference Call August 2, 2023 8:00 AM ET Company Participants Gary Maharaj - President & Chief Executive Officer Timothy Arens - Chief Financial Office
Surmodics (SRDX) Q3 Earnings Top Estimates, FY23 View Up
02:15pm, Thursday, 03'rd Aug 2023
Surmodics (SRDX) reports a solid fiscal third quarter top line on the back of robust Medical Device revenues.
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
11:12am, Wednesday, 02'nd Aug 2023
The headline numbers for SurModics (SRDX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
SurModics (SRDX) Surpasses Q3 Earnings and Revenue Estimates
10:27am, Wednesday, 02'nd Aug 2023
SurModics (SRDX) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of a loss of $0.46 per share. This compares to loss of $0.34 per share a year ago.
Three Reasons to Add Surmodics (SRDX) Stock to Your Portfolio
12:51pm, Wednesday, 28'th Jun 2023
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
Why Shares of Surmodics Jumped This Week
10:27am, Friday, 23'rd Jun 2023
Surmodics is a medical device maker that makes coatings for medical devices and manufactures chemicals for diagnostic immunoassay tests The company will make a drug-coated balloon that will be sold by
Surmodics (SRDX) Rallies on FDA Approval for SurVeil DCB
07:18am, Wednesday, 21'st Jun 2023
Surmodics' (SRDX) SurVeil DCB is indicated to treat percutaneous transluminal angioplasty in peripheral artery disease patients. Abbott will initiate commercialization of SurVeil DCB, per a deal with
Strength Seen in SurModics (SRDX): Can Its 16.1% Jump Turn into More Strength?
03:33am, Wednesday, 21'st Jun 2023
SurModics (SRDX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Surmodics' (SRDX) Receipt of New FDA Nod to Boost Patient Care
12:20pm, Friday, 16'th Jun 2023
Surmodics' (SRDX) receipt of FDA's clearance is expected to expand the treatment range of the Pounce platform and serve a wider patient pool.
Why Shares of Surmodics Soared on Tuesday
01:11pm, Tuesday, 13'th Jun 2023
Surmodics makes coatings for medical devices and manufactures chemicals for diagnostic immunoassay tests. The company said it hopes to get approval for its drug-coated balloon vascular device by the f
Top 5 Health Care Stocks That Could Blast Off In May - Coherus BioSciences (NASDAQ:CHRS), Intercept Pharma (NASDAQ:ICPT)
08:56am, Friday, 26'th May 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Surmodics (SRDX) Q2 Earnings Top Estimates, FY23 View Revised
12:10pm, Thursday, 27'th Apr 2023
Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues.
Surmodics, Inc (SRDX) Q2 2023 Earnings Call Transcript
12:24pm, Wednesday, 26'th Apr 2023
Surmodics, Inc (SRDX) Q2 2023 Earnings Call Transcript.
